Straumann Holding AG (OTCMKTS:SAUHY) Sees Large Decrease in Short Interest

Straumann Holding AG (OTCMKTS:SAUHYGet Free Report) was the target of a significant drop in short interest in March. As of March 13th, there was short interest totaling 19,458 shares, a drop of 67.0% from the February 26th total of 58,892 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 767,686 shares, the days-to-cover ratio is presently 0.0 days. Based on an average daily trading volume, of 767,686 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.0% of the shares of the stock are sold short.

Straumann Stock Up 3.0%

Shares of OTCMKTS:SAUHY traded up $0.30 during trading on Wednesday, hitting $10.41. 3,080 shares of the company were exchanged, compared to its average volume of 224,688. Straumann has a 1-year low of $9.44 and a 1-year high of $14.18. The business’s 50 day moving average is $11.69 and its 200-day moving average is $11.66.

Analysts Set New Price Targets

A number of research analysts have issued reports on SAUHY shares. Citigroup reiterated a “sell” rating on shares of Straumann in a research report on Wednesday, January 14th. Morgan Stanley restated an “underweight” rating on shares of Straumann in a research note on Monday, December 15th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, two have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold”.

Get Our Latest Stock Report on SAUHY

About Straumann

(Get Free Report)

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.

Further Reading

Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.